Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE3.6300
- TODAY'S CHANGE (%)0.1500 (4.3103%)
- Bid / Lots3.4500/ 15
- Ask / Lots3.6600/ 2
- Open / Previous Close3.4900 / 3.4800
- Day Range
- 52 Week Range
- Volume572,234
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 5744 | 3.488 |
| 09:34 ET | 1239 | 3.49 |
| 09:38 ET | 100 | 3.48 |
| 09:39 ET | 5300 | 3.49 |
| 09:41 ET | 17460 | 3.415 |
| 09:43 ET | 19132 | 3.425 |
| 09:45 ET | 4418 | 3.42 |
| 09:48 ET | 19232 | 3.415 |
| 09:50 ET | 2936 | 3.44 |
| 09:52 ET | 11286 | 3.415 |
| 09:54 ET | 300 | 3.415 |
| 09:56 ET | 2159 | 3.425 |
| 09:57 ET | 1213 | 3.405 |
| 09:59 ET | 1500 | 3.405 |
| 10:01 ET | 1396 | 3.41 |
| 10:03 ET | 958 | 3.42 |
| 10:06 ET | 2240 | 3.42 |
| 10:08 ET | 701 | 3.42 |
| 10:10 ET | 5742 | 3.43 |
| 10:12 ET | 3404 | 3.44 |
| 10:14 ET | 2129 | 3.425 |
| 10:15 ET | 106 | 3.42 |
| 10:17 ET | 1100 | 3.415 |
| 10:19 ET | 13408 | 3.45 |
| 10:21 ET | 1600 | 3.485 |
| 10:24 ET | 3000 | 3.4802 |
| 10:26 ET | 5000 | 3.475 |
| 10:30 ET | 4100 | 3.49 |
| 10:32 ET | 6408 | 3.49 |
| 10:33 ET | 200 | 3.485 |
| 10:35 ET | 100 | 3.515 |
| 10:39 ET | 459 | 3.51 |
| 10:42 ET | 1700 | 3.515 |
| 10:44 ET | 100 | 3.52 |
| 10:46 ET | 908 | 3.545 |
| 10:48 ET | 33982 | 3.58 |
| 10:51 ET | 1492 | 3.585 |
| 10:53 ET | 1205 | 3.575 |
| 10:55 ET | 3281 | 3.572 |
| 10:57 ET | 1946 | 3.575 |
| 11:00 ET | 200 | 3.575 |
| 11:02 ET | 4141 | 3.585 |
| 11:04 ET | 1804 | 3.565 |
| 11:06 ET | 129 | 3.56 |
| 11:08 ET | 738 | 3.56 |
| 11:09 ET | 3322 | 3.575 |
| 11:11 ET | 12622 | 3.5801 |
| 11:15 ET | 7957 | 3.5609 |
| 11:18 ET | 3300 | 3.57 |
| 11:20 ET | 326 | 3.565 |
| 11:26 ET | 100 | 3.565 |
| 11:27 ET | 2397 | 3.56 |
| 11:29 ET | 2500 | 3.555 |
| 11:33 ET | 300 | 3.565 |
| 11:36 ET | 100 | 3.57 |
| 11:40 ET | 332 | 3.565 |
| 11:42 ET | 100 | 3.57 |
| 11:44 ET | 1091 | 3.565 |
| 11:45 ET | 16716 | 3.58 |
| 11:47 ET | 100 | 3.575 |
| 11:49 ET | 3043 | 3.58 |
| 11:51 ET | 500 | 3.5899 |
| 11:54 ET | 200 | 3.585 |
| 11:56 ET | 1400 | 3.59 |
| 11:58 ET | 600 | 3.6 |
| 12:00 ET | 300 | 3.6 |
| 12:02 ET | 9298 | 3.585 |
| 12:03 ET | 200 | 3.59 |
| 12:07 ET | 100 | 3.59 |
| 12:09 ET | 2000 | 3.585 |
| 12:12 ET | 8061 | 3.585 |
| 12:14 ET | 100 | 3.585 |
| 12:16 ET | 634 | 3.59 |
| 12:23 ET | 100 | 3.59 |
| 12:25 ET | 100 | 3.59 |
| 12:27 ET | 1791 | 3.595 |
| 12:30 ET | 100 | 3.6 |
| 12:32 ET | 500 | 3.595 |
| 12:34 ET | 400 | 3.595 |
| 12:36 ET | 209 | 3.5997 |
| 12:38 ET | 100 | 3.595 |
| 12:39 ET | 15286 | 3.605 |
| 12:41 ET | 261 | 3.605 |
| 12:43 ET | 100 | 3.605 |
| 12:52 ET | 1436 | 3.60671 |
| 12:56 ET | 900 | 3.625 |
| 12:57 ET | 1100 | 3.625 |
| 12:59 ET | 2428 | 3.605 |
| 01:03 ET | 1100 | 3.615 |
| 01:08 ET | 2063 | 3.62 |
| 01:12 ET | 100 | 3.625 |
| 01:14 ET | 320 | 3.6299 |
| 01:15 ET | 100 | 3.625 |
| 01:21 ET | 300 | 3.635 |
| 01:24 ET | 200 | 3.635 |
| 01:26 ET | 8900 | 3.641 |
| 01:28 ET | 6225 | 3.645 |
| 01:30 ET | 200 | 3.635 |
| 01:33 ET | 662 | 3.645 |
| 01:35 ET | 2039 | 3.638 |
| 01:37 ET | 484 | 3.635 |
| 01:39 ET | 542 | 3.64 |
| 01:42 ET | 2208 | 3.625 |
| 01:44 ET | 100 | 3.6201 |
| 01:51 ET | 569 | 3.625 |
| 01:53 ET | 234 | 3.6294 |
| 01:57 ET | 400 | 3.625 |
| 02:00 ET | 200 | 3.625 |
| 02:02 ET | 207 | 3.625 |
| 02:04 ET | 2519 | 3.62 |
| 02:06 ET | 200 | 3.615 |
| 02:08 ET | 1375 | 3.61 |
| 02:11 ET | 1300 | 3.615 |
| 02:13 ET | 100 | 3.625 |
| 02:15 ET | 314 | 3.625 |
| 02:18 ET | 1732 | 3.6383 |
| 02:20 ET | 1110 | 3.625 |
| 02:24 ET | 200 | 3.625 |
| 02:26 ET | 1000 | 3.615 |
| 02:27 ET | 2291 | 3.61 |
| 02:29 ET | 1150 | 3.61 |
| 02:31 ET | 300 | 3.61 |
| 02:33 ET | 9834 | 3.615 |
| 02:36 ET | 754 | 3.615 |
| 02:40 ET | 200 | 3.615 |
| 02:42 ET | 307 | 3.615 |
| 02:45 ET | 400 | 3.625 |
| 02:47 ET | 934 | 3.615 |
| 02:51 ET | 447 | 3.625 |
| 02:54 ET | 2481 | 3.625 |
| 02:56 ET | 1126 | 3.615 |
| 02:58 ET | 1100 | 3.615 |
| 03:02 ET | 470 | 3.615 |
| 03:03 ET | 100 | 3.61 |
| 03:05 ET | 1947 | 3.615 |
| 03:07 ET | 5000 | 3.6199 |
| 03:09 ET | 281 | 3.615 |
| 03:12 ET | 56721 | 3.635 |
| 03:14 ET | 1786 | 3.635 |
| 03:16 ET | 2800 | 3.63 |
| 03:18 ET | 982 | 3.625 |
| 03:20 ET | 1715 | 3.615 |
| 03:21 ET | 1031 | 3.6 |
| 03:23 ET | 900 | 3.61 |
| 03:25 ET | 407 | 3.61 |
| 03:27 ET | 100 | 3.605 |
| 03:30 ET | 6221 | 3.61 |
| 03:34 ET | 6958 | 3.605 |
| 03:36 ET | 2270 | 3.6 |
| 03:38 ET | 1100 | 3.6 |
| 03:39 ET | 1000 | 3.6 |
| 03:41 ET | 1328 | 3.6082 |
| 03:43 ET | 500 | 3.605 |
| 03:45 ET | 600 | 3.6 |
| 03:48 ET | 3363 | 3.595 |
| 03:50 ET | 300 | 3.595 |
| 03:52 ET | 400 | 3.59 |
| 03:54 ET | 500 | 3.595 |
| 03:56 ET | 6117 | 3.61 |
| 03:57 ET | 1802 | 3.62 |
| 03:59 ET | 15648 | 3.63 |
Sep 19, 2024
Press Release: Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer, from 7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
7:00AM ET on Thursday Sep 19, 2024 by Dow JonesAutolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer, from 7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
7:00AM ET on Thursday Sep 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 926.0M | -3.1x | --- |
IGM Biosciences Inc | 940.8M | -4.7x | --- |
Sana Biotechnology Inc | 949.9M | -3.7x | --- |
Cullinan Therapeutics Inc | 1.0B | -5.5x | --- |
CARGO Therapeutics Inc | 848.8M | -5.0x | --- |
Applied Therapeutics Inc | 965.9M | -5.5x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $926.0M |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.04 |
EPS | $-1.16 |
Book Value | --- |
P/E Ratio | -3.1x |
Price/Sales (TTM) | 88.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,775.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
